Skip to main content
See every side of every news story
Published • loading... • Updated

Desjardins Forecasts Strong Price Appreciation for Extendicare (TSE:EXE) Stock

Summary by thecerbatgem.com
Extendicare (TSE:EXE – Get Free Report) had its price target increased by Desjardins from C$39.00 to C$39.50 in a research report issued to clients and investors on Monday, BayStreet reports. The firm currently has a “buy” rating on the stock. Desjardins‘s price target would indicate a potential upside of 40.32% from the stock’s current price. […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

thecerbatgem.com broke the news on Monday, November 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal